Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Receivables (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Receivables data on record, last reported at $14.8 million in Q4 2025.

  • For Q4 2025, Receivables rose 78.87% year-over-year to $14.8 million; the TTM value through Dec 2025 reached $14.8 million, up 78.87%, while the annual FY2025 figure was $14.8 million, 78.87% up from the prior year.
  • Receivables reached $14.8 million in Q4 2025 per TCNNF's latest filing, up from $10.5 million in the prior quarter.
  • Across five years, Receivables topped out at $32.3 million in Q2 2023 and bottomed at $2.6 million in Q1 2021.
  • Average Receivables over 5 years is $11.8 million, with a median of $8.9 million recorded in 2021.
  • Peak YoY movement for Receivables: soared 2774.68% in 2021, then crashed 78.36% in 2023.
  • A 5-year view of Receivables shows it stood at $8.9 million in 2021, then soared by 249.91% to $31.0 million in 2022, then plummeted by 78.36% to $6.7 million in 2023, then grew by 23.65% to $8.3 million in 2024, then surged by 78.87% to $14.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $14.8 million in Q4 2025, $10.5 million in Q3 2025, and $10.8 million in Q2 2025.